CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −300 | $200.79 | $60K | 232,985 |
| 2026-04-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,778 | $202.01 | $359K | 231,207 |
| 2026-04-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −3,213 | $203.07 | $652K | 227,994 |
| 2026-04-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,200 | $203.83 | $245K | 226,794 |
| 2026-04-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,909 | $205.00 | $391K | 224,885 |
| 2026-03-31 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Option exercise | +41,708 | $9.59 | $400K | 2,352,480 |
| 2026-03-31 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Option exercise · Stock Option (right to buy) | −41,708 | 58,292 | ||
| 2026-03-20 | Sheena Jonathan Director | Sale 10b5-1 | −239 | $198.85 | $48K | 21,543 |
| 2026-03-20 | Sheena Jonathan Director | Sale 10b5-1 | −140 | $199.82 | $28K | 21,403 |
| 2026-03-20 | Sheena Jonathan Director | Sale 10b5-1 | −371 | $200.97 | $75K | 21,032 |
| 2026-03-20 | Sheena Jonathan Director | Sale 10b5-1 | −235 | $198.49 | $47K | 21,547 |
| 2026-03-20 | Sheena Jonathan Director | Sale 10b5-1 | −235 | $199.88 | $47K | 21,312 |
| 2026-03-20 | Sheena Jonathan Director | Sale 10b5-1 | −280 | $200.90 | $56K | 21,032 |
| 2026-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −300 | $196.27 | $59K | 262,025 |
| 2026-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −956 | $197.84 | $189K | 261,069 |
| 2026-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −1,814 | $198.65 | $360K | 259,255 |
| 2026-03-16 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Option exercise 10b5-1 | +50,000 | $9.59 | $480K | 2,360,772 |
| 2026-03-16 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −100 | $190.07 | $19K | 2,360,672 |
| 2026-03-16 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −300 | $190.68 | $57K | 2,360,372 |
| 2026-03-16 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −900 | $192.43 | $173K | 2,359,472 |
Page 22 of 39 · 767 trades